EHTG 9th Annual Meeting 2025

REQUEST FOR PROPOSALS TO HOST THE 2025 9TH ANNUAL MEETING OF THE EUROPEAN HEREDITARY TUMOUR GROUP

Dear EHTG Society Members,

We are delighted to announce that the European Hereditary Tumour Group (EHTG) is now accepting applications to host the 2025 9th EHTG Annual Meeting!

This is a prestigious opportunity to bring Europe’s leading hereditary cancer experts to your city and showcase your institution's dedication and commitment to hereditary cancer research and clinical care.

As host, you will have the privilege of helping to shape the scientific program, foster collaboration among Europe's top experts in hereditary cancer, and advance our understanding of these complex diseases.

We encourage members who are interested in hosting to submit a tentative expression of interest that includes:

City and Venue: Provide details about the proposed city and venue, including accessibility, capacity, facilities, and proximity to hotels and transport links. Highlight what makes your city an attractive destination for our international delegates.
Tentative Program: Outline a tentative program for the meeting, including your vision for keynote speakers, symposiums, and social events.
Budget: An estimated budget for the event, including potential sponsorships, registration fees, and cost-saving measures.
Local Organizing Committee: Identify the local team that would take responsibility for the organization and delivery of the event.

Please indicate your intention to toni.seppala@tuni.fi no later than 10th February 2024.

A detailed Request for Proposal will be sent out to those expressing their interest, and the deadline for full proposals will be March 31st 2024. The applicant will be notified by April 15th 2024.

We thank you in advance for your enthusiasm and commitment to the EHTG and look forward to receiving your expressions of interest and subsequently full applications.

Best Regards,

Gabriela Möslein, chair, European Hereditary Tumour Group

Toni Seppälä, vice-chair, European Hereditary Tumour Group